Dithrocream 0.5%w/w Ireland - English - HPRA (Health Products Regulatory Authority)

dithrocream 0.5%w/w

dermal laboratories ltd - dithranol - cream - 0.5 percent weight/weight - antracen derivatives; dithranol

Dithrocream 0.1%w/w Ireland - English - HPRA (Health Products Regulatory Authority)

dithrocream 0.1%w/w

dermal laboratories ltd - dithranol - cream - 0.1 percent weight/weight - antracen derivatives; dithranol

Dithrocream 1% w/w Ireland - English - HPRA (Health Products Regulatory Authority)

dithrocream 1% w/w

dermal laboratories ltd - dithranol - cream - 1.0 percent weight/weight - antracen derivatives; dithranol

Dithrocream 0.25%w/w Ireland - English - HPRA (Health Products Regulatory Authority)

dithrocream 0.25%w/w

dermal laboratories ltd - dithranol - cream - 0.25 percent weight/weight - antracen derivatives; dithranol

Dithrocream 2% w/w Ireland - English - HPRA (Health Products Regulatory Authority)

dithrocream 2% w/w

dermal laboratories ltd - dithranol - cream - 2 percent weight/weight - antracen derivatives; dithranol

GAMUNEX normal immunoglobulin (Human) 20g/200mL intravenous solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 20g/200ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: glycine; water for injections - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.

GAMUNEX normal immunoglobulin (Human) 10g/100mL intravenous solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 10g/100ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections; glycine - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.

GAMUNEX normal immunoglobulin (Human) 5g/50mL intravenous solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 5g/50ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: glycine; water for injections - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.

GAMUNEX normal immunoglobulin (Human) 2.5g/25mL intravenous solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 2.5g/25ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections; glycine - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.

GAMUNEX normal immunoglobulin (Human) 1g/10mL intravenous solution vial Australia - English - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 1g/10ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: glycine; water for injections - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.